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S U M M A R Y
Nodding syndrome (NS) is an unexplained neurological illness that mainly affects children aged between
5 and 15 years. NS has so far been reported from South Sudan, northern Uganda, and Tanzania, but in
spite of extensive investigations, the aetiology remains unknown. We hypothesize that blackﬂies
(Diptera: Simuliidae) infected with Onchocerca volvulus microﬁlariae may also transmit another
pathogen. This may be a novel neurotropic virus or an endosymbiont of the microﬁlariae, which causes
not only NS, but also epilepsy without nodding. This hypothesis addresses many of the questions about
NS that researchers have previously been unable to answer. An argument in favour of the hypothesis is
the fact that in Uganda, the number of new NS cases decreased (with no new cases reported since 2013)
after ivermectin coverage was increased and with the implementation of a programme of aerial spraying
and larviciding of the large rivers where blackﬂies were breeding. If conﬁrmed, our hypothesis will
enable new strategies to control NS outbreaks.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/3.0/).
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Nodding syndrome (NS) is an unexplained neurological illness
that has so far been reported from South Sudan, northern Uganda,
and Tanzania.1 NS mainly occurs in children aged between 5 and
15 years. The ﬁrst clinical symptom is often an involuntary
nodding of the head in a previously healthy child. Other types of
epileptic seizures may follow, which in some children are
accompanied by cognitive deterioration and stunted growth,
leading to dwarﬁsm and the absence of development of secondary
sexual characteristics.1
Various infectious, toxic, nutritional, psychosocial, and genetic
causes have been proposed, but none have been conﬁrmed.
However, there appears to be a link between NS and onchocercia-
sis. NS is only known to occur in onchocerciasis endemic areas, and
case–control studies have demonstrated a higher prevalence of* Corresponding author.
E-mail address: bcoleb@itg.be (R. Colebunders).
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license (http://creativecommons.org/licenses/by-nc-sa/3.0/).onchocerciasis in individuals with NS than in controls.1 A high
prevalence of epilepsy has also been described in many
onchocerciasis endemic areas,2 and higher microﬁlarial loads have
been found in skin snips of onchocerciasis patients with epilepsy
than in those without.3 PCR tests on the cerebrospinal ﬂuid (CSF) of
NS patients have failed to identify Onchocerca volvulus DNA,4,5 but
these results are difﬁcult to interpret as they may have been
complicated by previous treatment with ivermectin.6 However,
because O. volvulus microﬁlariae are not known to invade the brain,
it is difﬁcult to understand how O. volvulus could directly cause the
neurological damage seen in NS patients.
We therefore propose the aetiological hypothesis below.
2. Hypothesis
The association between NS and onchocerciasis may be
explained by the existence of a common vector – blackﬂies
(Simulium spp – transmitting O. volvulus) and a second pathogen
involved in the aetiology of NS.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
Figure 1. Number of new cases of nodding syndrome between 1997 and 2013 in the
districts of Kitgum, Lamwo, and Pader, in northern Uganda.
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transmitted by blackﬂies co-infected with O. volvulus microﬁlariae.
Many laboratory studies have shown that arboviral transmission is
enhanced in mosquitoes and other Diptera that concurrently
ingest microﬁlariae,7,8 and the same could be true for blackﬂies. In
mosquitoes, microﬁlariae penetrate the midgut and introduce the
virus directly into the haemocoel, allowing them to become
infectious more quickly than normal.8 This has been demonstrated
in experiments with Aedes taeniorhynchus co-infected with Rift
Valley fever virus, and Aedes aegypti co-infected with dengue virus
type 2 and Brugia malayi microﬁlariae.7 It was also found that the
biting midge, Culicoides nubeculosus, became infectious after
ingesting blue tongue virus and Onchocerca cervicalis microﬁlariae,
but not after ingesting the virus alone.9
A pathogen could also be an endosymbiont of O. volvulus
microﬁlariae, for example Wolbachia bacteria. Wolbachia are known
to play a role in the pathogenicity of onchocerciasis.10 Toxins
secreted by Wolbachia are able to cause pruritus, skin inﬂammation,
and ocular lesions.10,11 However, we do not currently know how
these toxins could damage the central nervous system (CNS) in the
absence of microﬁlariae penetrating the brain.
The hypothesis of a new pathogen transmitted by blackﬂies
addresses many of the questions about NS that researchers have
previously been unable to answer, including those listed below.
2.1. Why is NS only present in a limited number of onchocerciasis
endemic areas?
The distribution of NS could be limited by the distribution of an
appropriate disease vector. It is possible that only certain
(cyto)species of blackﬂy are able to transmit the pathogen. It is
also possible that NS occasionally occurs in hypo- and mesoen-
demic areas for O. volvulus, but only becomes epidemic in areas
that are hyperendemic for O. volvulus. An argument for the latter is
supported by the high prevalence of epilepsy seen in many
onchocerciasis hyperendemic areas, and that NS-like features have
been reported in several other onchocerciasis hyperendemic areas
in the past. In 1938, a Mexican physician described a syndrome in
Chiapas and Oaxaca, Mexico, characterized by epileptic seizures,
stunted growth, and mental retardation in patients with oncho-
cerciasis.12 In Mabira Forest, 60 km east of Kampala, Uganda, a
‘Nakalanga syndrome’ outbreak (a syndrome with symptoms
similar to NS) was described in 1950.13 NS-like features have also
been reported in other onchocerciasis endemic areas in Liberia,14
western Uganda,15 Burundi,16 and possibly the Central African
Republic, Ethiopia, Mali,17 and Cameroon.18
2.2. Why do NS epidemics appear and disappear?
An NS epidemic may appear in onchocerciasis hyperendemic
areas when a non-immune population migrates to an area
containing blackﬂies infected with an ‘NS pathogen’. Population
displacement resulting from civil conﬂict has preceded NS outbreaks
in both northern Uganda and South Sudan. An NS epidemic may
subsequently decrease with increasing herd immunity. It may also
decrease with increasing ivermectin coverage. This will reduce the
likelihood of blackﬂies becoming infected with microﬁlariae and
therefore transmitting a pathogen. NS epidemics may be interrupted
by insecticide or larvicide use against blackﬂies.
2.3. How can the current epidemiological situation in the three
affected countries be explained?
2.3.1. Northern Uganda
Northern Uganda was engaged in a war with the Lord’s
Resistance Army between 1987 and 2008. About 1.8 million peoplein Gulu, Kitgum, and Pader districts were displaced into ‘protective’
internally displaced people camps, some for more than 15 years.
Before displacement, frequent contact with blackﬂy-infested rivers
had caused immunity in adults. Relief food was distributed in the
camps and water was collected from boreholes resulting in less
frequent contact with the rivers. As a result, children born in camps
lacked immunity against the ‘NS pathogen’. People were released
from the camps from 2006 and non-immune children came into
contact with infected blackﬂies at rivers near their home villages.
There was no ivermectin distribution during the war, and
community-directed treatment with ivermectin was only started
in 2009, and in the villages most affected by NS, in 2012. A
combined lack of immunity and the absence of an ivermectin
distribution programme potentially resulted in the NS epidemic19
(Figure 1).
A programme of aerial spraying and larviciding of the large
rivers where blackﬂies were breeding was implemented in
2012. This was followed by a decrease in the incidence of NS,
with no new cases ofﬁcially reported in 2013.20,21 The already
decreasing trend of new NS cases before spraying took place could
have been a consequence of the intensiﬁed ivermectin programme
(biannual distribution).
2.3.2. South Sudan
Sudan used insecticides to control river blindness until
autonomy in 1972, when spraying stopped due to a lack of
funding. People ﬂed into forests infested by blackﬂies during the
Second Sudanese Civil War (1983–2005) and it is conceivable that
because of insecticide spraying in the past, the population had
limited immunity. The ﬁrst cases of NS appeared around 199022
and the prevalence has been increasing since. The prevalence of NS
in Mvolo county has been estimated at 8.4% by the South Sudan
Relief and Rehabilitation Commission (4025 NS patients out of
48 100 people) (Anthony Amba; personal communication), which
is a doubling of prevalence compared to the 2003 estimate of
4.6%.23 There are still new NS cases occurring in South Sudan (Mr
S.A. Komoyangi, Chair, Diko Community Development Committee,
Western Equatoria State, South Sudan; personal communication).
The reason for this might be the low ivermectin coverage (only
distributed annually).
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Around 1850, the Wapogoro tribe ﬂed from the Ulanga plains to
isolated regions in the Mahenge mountains to avoid conﬂict with
the Ngoni.22 The prevalence of epilepsy in Mahenge was estimated
to be 2% in 197024 and 1.8% in 1989.25 Over the last 10 years, the
incidence of NS has been low and stable.26 Because insecticides and
larvicides have never been used in Mahenge, we hypothesize that
the population has been exposed to the ‘NS pathogen’ for a long
time. The fact that NS is endemic in Mahenge may be explained by
an increase in acquired immunity of the local population over a
very long period and good ivermectin coverage.
2.4. Why are only children affected?
Many infectious disease epidemics show a predisposition for
very young children. The onset of NS between the ages of 5 and
15 years is probably explained by the following: (1) protection of
very young children by the antibodies of their mothers; (2) the fact
that very young children are less likely to spend a lot of time near
rivers; (3) the incubation time of the disease; (4) treatment with
ivermectin is only started after the age of 5 years. If the pathogen is
a microﬁlarial endosymbiont, then young children may be at
particular risk of developing the disease. It is also possible that,
similar to other viral childhood infections, the ‘NS pathogen’ could
lead to immunity for life, explaining why adults rarely develop the
disease.
2.5. Why are non-immune adults not developing NS?
It may be that the rate of infection in blackﬂies is low. In the
event that the pathogen is a microﬁlarial endosymbiont, it may be
that you need to become infected many times, similar to
onchocerciasis, before you develop a serious disease. This could
explain the low risk of disease development seen in occasional
non-immune travellers who spend only a short time at the
riverside.
2.6. How can the severe stunting (dwarﬁsm) be explained?
Dwarﬁsm could be caused by an infection with the ‘NS
pathogen’ at an early age, when the child’s brain is still developing.
Hypothalamic-pituitary dysfunction has been described post-
encephalitis27 and a similar stunted growth and lack of secondary
sexual characteristics has also been observed in perinatally HIV-
infected children who survived up to 18 years without antiretro-
viral therapy,28 and in perinatally human T-cell lymphotropic virus
type 1 (HTLV-1)-infected children (K. Verdonck; personal com-
munication). It is unlikely that the pronounced dwarﬁsm is only
caused by malnourishment because not all these children are
particularly malnourished.
2.7. How should the CSF and brain magnetic resonance imaging (MRI)
ﬁndings observed in patients with NS be interpreted?
The CSF of patients with NS is generally clear, with glucose and
protein levels within normal limits.1,4,29 In a viral CNS infection
one would expect an increased cell count and an increased total
protein level. However, in subacute sclerosing panencephalitis, CSF
ﬁndings are usually acellular with a normal or mildly raised
protein concentration.30 Therefore normal CSF ﬁndings do not
exclude a chronic or subacute viral infection. Brain MRI has only
been performed in a limited number of patients with NS.4,29,31
None of the patients showed evidence of meningeal or parenchy-
mal inﬂammation, or a focal brain lesion caused by a parasitic
infection. Five patients from Tanzania and two patients from
Uganda had aspeciﬁc hippocampus abnormalities, and in ﬁveUgandan patients, cerebral atrophy was noted.1 Brain MRI do not
provide evidence of a viral CNS infection, but also do not suggest a
parasitic infection of the brain.
2.8. Can blackﬂies transmit pathogens?
Blackﬂies can transmit vesicular stomatitis New Jersey virus to
cattle, horses, and swine.32 There are no reports of blackﬂies
transmitting arboviruses to humans. However with over 1700
Simulium species described worldwide, it is plausible that
blackﬂies may transmit unidentiﬁed viruses from human and
zoonotic origin.
3. Directions for future research
More precise incidence data on NS, epilepsy, and onchocerciasis
in relation to blackﬂy distribution are required. At the same time,
research should focus on the search for a new pathogen. Previous
studies using multiplex PCR have not been able to identify a
pathogen in the serum or CSF of NS patients.33 However, such
methods may not be able to detect a new pathogen and it is
conceivable that once nodding appears, the ‘NS pathogen’ may no
longer be detectable in serum or even CSF. The way forward is to
plan a metagenomic study of blackﬂies, microﬁlariae, and human
samples (preferably brain tissue).
In conclusion, NS may be caused by a new pathogen transmitted
by blackﬂies. Similar to other vector-borne diseases, infection
depends on a combination of the amount of exposure, percentage
of insects carrying the pathogen, immunity, and chance. The
burden of disease may be considerable, as the ‘NS pathogen’ may
also cause epilepsy without nodding. The use of larvicides may be
able to stop epidemics; however, if vector control is not sustained
there may be an increase in clinical disease because of decreased
immunity. Improving ivermectin coverage and increasing the
frequency of its administration may reduce the capacity of the
blackﬂies to transmit the pathogen. The planning of a clinical trial
to evaluate these control strategies, either alone or in combination,
should be considered.
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